Health

Drugs, the first ten months of 2021 spending on direct purchases above the ceiling of 1632 billion.

ADVERTISING
Rome, 28 February – Aifa has made available the documents on the monthly monitoring of national and regional pharmaceutical expenditure for in the period January / October 2021, carried out on the basis of the agreed expenditure data and the summary accounting statements (Dcr) obtained from the Regions, as well as the data obtained from the new National Information System (NIS) of the Ministry of Health, regarding the traceability of the drug ( Ministerial Decree of 15 July 2004).

ADVERTISING

ADVERTISING
1 of 6